Previous 10 | Next 10 |
NORTHAMPTON, MA / ACCESSWIRE / September 21, 2023 / Alkermes September is Ovarian Cancer Awareness Month. We stand in solidarity with patients, caregivers and family members whose lives have been impacted by Ovarian Cancer. Our oncology team is dedicated to advancing research and developing pot...
NORTHAMPTON, MA / ACCESSWIRE / September 19, 2023 / The Alkermes Pathways Research Awards are open for applications! This program is open to all early-career investigators studying bipolar disorder or schizophrenia. With millions of people impacted by neurological disorders, more research is ur...
NORTHAMPTON, MA / ACCESSWIRE / September 18, 2023 / Alkermes On World Suicide Prevention Day, we remember all those affected by suicide. In 2020, the United States had 1 death by suicide every 11 minutes. But help is available. If you or someone you know is in crisis, dial 988 to find help and...
Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress PR Newswire — Poster Presentations Highlight Company's Broad Research Commitment to Serious Mental Illness, Addiction and Narcolepsy — DUBLIN , Sept. 11, 2023 /PRNe...
- Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project - - Application Period to Run From Sept. 15, 2023 Through Nov. 30, 2023 - DUBLIN, IRELAND / ACCESSWIRE / September 7, 2023 / Alkermes plc (Nasdaq:ALKS) announced that it will begin accepting applic...
Alkermes Announces Launch of 6th Annual Alkermes Pathways Research Awards® Program PR Newswire — Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project — — Application Period to Run From Sept. 15, 2023 ...
Alkermes Announces Recipients of 2023 Alkermes Inspiration Grants® Program PR Newswire – Competitive Grants Program Awards Funding to 11 Innovative Programs Focused on People Living with Addiction, Serious Mental Illness or Cancer – DUBLIN ...
2023-08-30 10:38:05 ET More on Alkermes Alkermes: A Complicated Story Right Now Lybalvi: Weighing In Light, But Tipping Alkermes' Scales Alkermes plc 2023 Q2 - Results - Earnings Call Presentation Alkermes plc ( ALKS ) Q2 2023 Earnings Call Transcript ...
Alkermes Announces Settlement With Teva Related to VIVITROL® Patent Litigation PR Newswire — Company Grants Teva a License to Market Generic VIVITROL Beginning in January 2027 — DUBLIN , Aug. 30, 2023 /PRNewswire/ -- Alkermes plc (N...
NORTHAMPTON, MA / ACCESSWIRE / August 28, 2023 / Alkermes Equality for women matters every day, and at Alkermes we're proud to empower our female colleagues across the organization. In the life sciences industry, striving for gender equality means envisioning a future where the upcoming generat...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...